New Expert Consensus Aims to Standardize Surgery for Childhood Kidney Cancer

A new expert consensus provides 34 recommendations to standardize surgical decision-making for unilateral Wilms tumor, aiming to reduce complications and improve outcomes for children with the most common renal cancer.

DC Metrowire Staff
••Healthcare
New Expert Consensus Aims to Standardize Surgery for Childhood Kidney Cancer

Surgical management of unilateral Wilms tumor (WT), the most common primary malignant renal tumor in children, varies widely across centers and specialties. A new expert consensus developed by the Oncology Surgery Group and Urology Surgery Group of the Pediatric Surgery Branch of the Chinese Medical Association sets out a standardized framework to address this inconsistency. The guidance, published (DOI: 10.1136/wjps-2026-001204) in World Journal of Pediatric Surgery on 17 June 2026, offers 34 recommendations based on 17 clinical questions, covering surgical timing, biopsy, incision, renal vessel control, lymph node sampling, tumor thrombus, rupture, recurrence, metastases, nephron-sparing surgery (NSS), minimally invasive surgery (MIS), horseshoe kidney, special populations, and follow-up.

The consensus matters because nonstandard procedures can cause tumor rupture, incomplete staging, recurrence, and iatrogenic progression. While outcomes for WT have improved through advances in molecular diagnosis, chemotherapy, radiotherapy, and surgery, surgical practice remains inconsistent, particularly for large tumors, adjacent-organ invasion, intravascular extension, NSS, and lymph node biopsy. Surgeons also come from different specialties, which may contribute to variations in practice. Imaging with computed tomography (CT) and magnetic resonance imaging (MRI) helps identify risk features but has limited sensitivity for rupture, and lymph node size on imaging cannot reliably confirm metastasis.

Key recommendations include immediate radical nephrectomy for resectable tumors, with preoperative chemotherapy advised for selected patients with high-risk or initially unresectable disease. Immediate surgery is discouraged in certain circumstances, such as confirmed germline WT1 mutation, solitary kidney, severe anesthetic risk, or tumor thrombus above the hepatic veins. Percutaneous biopsy is generally not recommended but is suggested when renal origin is unclear, benign or non-WT disease is suspected, or in stage IV patients and those older than 10 years. A transverse abdominal or thoracoabdominal incision is preferred, and renal pedicle vessels should be ligated early when possible.

Adequate lymph node sampling—ideally 6 to 10 nodes from renal hilar, aortocaval, paraaortic, aortic bifurcation, celiac trunk, superior mesenteric artery, and iliac sites—improves staging and keeps the false-negative rate below 10%. The ureter should be divided distal to the iliac bifurcation, and the adrenal gland and adjacent organs should be preserved unless directly invaded. Tumor thrombus management follows the Daum classification, with neoadjuvant chemotherapy for thrombi above the hepatic veins and multidisciplinary care for atrial extension. For recurrence, second-line chemotherapy is preferred; late isolated pulmonary or central nervous system lesions may be resected. NSS is not routine and requires strict criteria, while MIS may be considered in selected cases at experienced centers, with conversion to open surgery when necessary.

The consensus is intended as a practical framework rather than a rigid protocol. Complete resection and accurate staging remain non-negotiable, but surgeons must balance oncologic control with renal preservation and avoid unnecessary harm. Multidisciplinary discussion is essential for complex thrombus, recurrent disease, and unusual presentations, and conversion from MIS to open surgery should be viewed as sound judgment rather than failure. The framework can help pediatric surgeons, oncologists, urologists, radiologists, and pathologists align care around common standards, and in resource-limited settings it may guide referral and multidisciplinary planning. The authors call for future studies to refine patient selection for NSS and MIS, improve rupture prediction, standardize lymph node mapping, and clarify anticoagulation and radiotherapy decisions.

The consensus is also supported by Chuanlink Innovations, which fosters innovation and connection in medical research.

Blockchain Registration

QR Code for Blockchain Registration